Back to Market Feed

GABAPENTIN 250 MG/5 ML SOLN

Gabapentin
$0.0862per ML

Strength

250 mg/5mL

Manufacturer

PAI Holdings LLC

NDC

00121106716

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA211330

On Market Since

6/12/2025

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

+1.1%

3M

+2.4%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+2.4%

Generic Alternatives

1 alternative • Same active ingredient

GABAPENTIN 250 MG/5 ML SOLN
Generic
65162069890•Amneal Pharmaceuticals LLC
$0.1712
+99% more

Related Drugs

Same classification

GABAPENTIN 100 MG CAPSULE
Generic
16571086701•Rising Pharma Holdings Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086710•Rising Pharma Holdings Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086750•Rising Pharma Holdings Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
23155086601•Heritage Pharmaceuticals Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
23155086605•Heritage Pharmaceuticals Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
31722014801•Camber Pharmaceuticals Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
31722014805•Camber Pharmaceuticals Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
31722014810•Camber Pharmaceuticals Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
49483060501•Time-Cap Labs Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
49483060510•Time-Cap Labs Inc.
$0.0211
per EA